Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (28)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (39)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

630 result(s) found, displaying 391 to 400

PHARMACOR CEPHALEXIN 250 cefalexin 250mg capsule blister pack Cancelled under s30(1)(c)

20 July 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
PHARMACOR CEPHALEXIN 500 cefalexin 500mg capsule blister pack Cancelled under s30(1)(c)

20 July 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ESOMEPRAZOLE SUN esomeprazole sodium 40mg powder for injection glass vial (212516)

14 January 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ESOMEPRAZOLE SUN esomeprazole sodium 40mg powder for injection glass vial.
CANDESARTAN HCTZ RBX 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under s30(1)

7 June 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
CANDESARTAN HCTZ RBX 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)

7 June 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
CANDESARTAN HCTZ RBX 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet bottle Cancelled under s30(1)

6 June 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
CANDESARTAN HCTZ RBX 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack Cancelled under s30(1)

6 June 2017

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial (202826)

11 December 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial.
LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial (202827)

11 December 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 50mg/25mL Liposome Injection concentrate glass vial.
MEMANTINE RANBAXY memantine hydrochloride 10 mg tablet blister pack (201740)

28 November 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MEMANTINE RANBAXY memantine hydrochloride 10 mg tablet blister pack.

Pages

First page
Previous page
…
Page 36
Page 37
Page 38
Page 39
Current page 40
Page 41
Page 42
Page 43
Page 44
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.